View allAll Photos Tagged brainstorming
012
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:35 PM
THE NEXT BIG THING
When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.
Dr. Jessica Mega, Chief Medical Officer, Verily
Dr. Bryan Roberts, Partner, Venrock
Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune
Photograph by Stuart Isett/Fortune
012
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:35 PM
THE NEXT BIG THING
When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.
Dr. Jessica Mega, Chief Medical Officer, Verily
Dr. Bryan Roberts, Partner, Venrock
Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune
Photograph by Stuart Isett/Fortune
020
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:05 AM
THE NEXT ENDANGERED SPECIES: THE DOCTOR
Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?
Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic
Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
029
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
12:00 PM
THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS
Why you’re an addict and you don’t even know it: A 21st century dilemma.
Tristan Harris, Co-founder, Time Well Spent
Photograph by Stuart Isett/Fortune
012
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:35 PM
THE NEXT BIG THING
When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.
Dr. Jessica Mega, Chief Medical Officer, Verily
Dr. Bryan Roberts, Partner, Venrock
Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune
Photograph by Stuart Isett/Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
BANKING ON CHANGE
A decade after the financial crisis, Bank of America’s profits are at record highs, yet persistently low interest rates and rising recession fears pose risks. Meanwhile, online challengers and new technologies such as A.I. have pushed it to raise the bar on modern banking. A conversation with the head of one of America’s top banks about leading in uncertain times.
Brian Moynihan, Chairman and CEO, Bank of America
Moderator: Shawn Tully, Senior Editor-at-Large, FORTUNE
photo by Rebecca Greenfield for Fortune
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
029
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
12:00 PM
THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS
Why you’re an addict and you don’t even know it: A 21st century dilemma.
Tristan Harris, Co-founder, Time Well Spent
Photograph by Stuart Isett/Fortune
038
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
2:55 PM
FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US
Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.
Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College
Photograph by Stuart Isett/Fortune
014
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
7:00 PM–9:00 PM
DINNER AND FEATURED INTERVIEW
Hosted by IBM Watson Health
WELCOME
Deborah DiSanzo, General Manager, IBM Watson Health
THE SECRET TO TONY ROBBINS’ SUCCESS
He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.
Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game
Interviewer: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
Mobile payments and blockchain have challenged the status quo of cross-border money transfers, putting pressure on traditional players. Yet money can be stubbornly hard to move, and the old systems hard to improve upon. A conversation between the leader of Zelle, a bank-owned mobile payments app that has eclipsed Venmo in transactions, and the CEO of 168-year-old Western Union, a leader in cross-border, cross-currency money movement and payments.
Lou Anne Alexander, Group President, Payment Solutions, Early Warning Services
Hikmet Ersek, President and CEO, Western Union
Moderator: Robert Hackett, Co-chair, Brainstorm Finance; Co-founding Editor, The Ledger; Senior Writer, FORTUNE
Photography by Rebecca Greenfield/Fortune
011
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
5:10 PM
PRECISION MEDICINE: WHERE IT’S WORKING AND WHY
The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.
Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School
Othman Laraki, Co-Founder and CEO, Color
Dr. Vijay Pande, General Partner, Andreessen Horowitz
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
Board a 65′ x 29′ open bridge deck catamaran, inspired by traditional Polynesian double-canoe and enjoy a two hour sail from Gurney’s Yacht Club, out and back, through the harbor and sound.
026
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
11:10 AM
A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER
Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.
Theresa Beech, President, Because of Daniel
Photograph by Stuart Isett/Fortune
029
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
12:00 PM
THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS
Why you’re an addict and you don’t even know it: A 21st century dilemma.
Tristan Harris, Co-founder, Time Well Spent
Photograph by Stuart Isett/Fortune
003
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:20 PM
U.S. HEALTH CARE: AT THE CROSSROADS
A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.
Mark Bertolini, Chairman and CEO, Aetna Inc.
Interviewer: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
017
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
7:45 AM
CONCURRENT BREAKFAST SOLUTION SESSIONS
THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?
Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?
Anu Acharya, CEO, Mapmygenome
Dr. Kevin Ban, Chief Medical Officer, athenahealth
Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare
Chrissa McFarlane, Chief Executive Officer, Patientory
Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute
Hal Wolf, President and CEO, Healthcare Information and Management Systems Society
Moderator: Dr. David B. Agus, University of Southern California
Photograph by Stuart Isett/Fortune
009
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
4:40 PM
THE MOTHER OF INVENTION
Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.
James Park, Co-founder and CEO, Fitbit
Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.
Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures
Photograph by Stuart Isett/Fortune
001
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
11:30 AM–1:00 PM
OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT
Hosted by PAREXEL
The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.
Dr. Udit Batra, CEO, MilliporeSigma
David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit
Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute
Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health
Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting
Photograph by Stuart Isett/Fortune
035
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
1:00 PM
CONCURRENT LUNCH SOLUTION SESSIONS
PATIENT TRIALS WE CAN ACTUALLY LEARN FROM
Hosted by City of Hope
The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.
Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Matt de Silva, Co-Founder, CEO and Director, Notable Labs
Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope
Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
024
Fortune Brainstorm Design 2018
Wednesday, March 7th, 2018
Singapore
13:00 - 14:45
LUNCH DISCUSSIONS
Choose 1 of 4
DISRUPTION X DESIGN
Design is a potent weapon for startups as well as giant global firms. Too often, however, new ventures—and the investors who fund them—make the mistake of assuming that new technology and more data is the solution to every problem. The most successful startups prevail because of their superb user experience, aesthetics, and ability to forecast and create solutions for challenges yet unknown. Entrepreneurs and experts share insights on the integral role disruptive design is playing in an increasingly competitive marketplace.
Robbie Antonio, Chief Executive Officer, Revolution Precrafted
Charles Hayes, Partner and Executive Managing Director, Asia, IDEO
Yuichiro Hori, Chief Executive Officer and Founder, Stellar Works
Kohei Nishiyama, Co-founder, Elephant Design Holdings; Founder and CEO, CUUSOO System
Moderator: Clay Chandler, Brainstorm Design
Photograph by Stefen Chow/Fortune
041
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:05 PM
TAKE TWO TERABYTES AND CALL ME IN THE MORNING: DATA’S GROWING ROLE IN THE MEDICAL TOOL BOX
At the core of precision medicine is precision: the critical need to hit, square on, a moving target in a body chock full of moving targets. To keep the aim sound, we need more than a steady hand, we need data. Smart data, and lots of it. That imperative has driven much of the innovation—and investment—in the current digital health transformation. Entrepreneurs and corporate leaders are now championing the role of big data in everything from drug development to predictive analytics in cancer diagnosis to hospital systems management—and putting billions of dollars behind these efforts. Do the numbers add up, or is the promise of big data yet another false medical miracle?
Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health
Dr. Kyu Rhee, Vice President and Chief Health Officer, IBM Corporation
Dr. Mona Siddiqui, Chief Data Officer, U.S. Dept. of Health and Human Services
Photograph by Stuart Isett/Fortune
016
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
7:45 AM
CONCURRENT BREAKFAST SOLUTION SESSIONS
WHY YOU SHOULD SLEEP THROUGH THIS SESSION
The data is real. A good night of sleep can have enormous benefits for our health, well-being, and productivity. Yet, despite the science, many of us continue to forgo the shut-eye we need. Part of the reason is a profound misunderstanding of productivity and where it comes from: While today’s digital world seems to demand that we’re always connected, there’s a smarter, healthier way to get more done. We explore what individuals and companies can do to create a well-rested workplace and what impact that can have on decision making, problem solving, and the bottom line. Can we really change the culture of ALWAYS ON? Rest assured, we can.
Liat Ben-Zur, Senior Vice-President, Connected Digital Platforms and Propositions, Royal Philips
Roger Ekirch, Professor of History, Virginia Tech
Dr. Lauren Hale, Professor, Family, Population, and Preventive Medicine; Core Faculty, Program in Public Health, Stony Brook University School of Medicine
Cheri Mah, Research Fellow, Human Performance Center, UC San Francisco
Moderator: David Cloud, CEO, National Sleep Foundation
Photograph by Stuart Isett/Fortune
008
Monday, September 24, 2018
Fortune Brainstorm Reinvent
Chicago, IL, USA
3:25 PM
REINVENTION AND THE BOARD
Boards comprised of the right mix of leaders can be much more than a practical and financial advisory body. What are the common obstacles that boards face and how can boards reshape their role to best support growth and innovation for the companies they serve?
John Chambers, Founder and CEO, JC2 Ventures
Wan Ling Martello, Executive Vice President and Chief Executive Officer Zone Asia, Oceania and sub-Saharan Africa (AOA), Nestlé
Ann Ziegler, Director, Hanesbrands, Wolters Kluwer, Groupon; Former Senior Vice President and CFO, CDW
Moderator: Clifton Leaf, Editor-in-Chief, Fortune
Photograph by Stuart Isett/Fortune
LIVING IN TOMORROW’S MATERIAL WORLD
As technology continues to advance, so will everything from access to credit to the way we pay for purchases. A look at what impact this evolving payments industry will have on customers and businesses of all sizes.
Patrick Gauthier, Vice President, Amazon Pay
Margaret Keane, Chief Executive Officer, Synchrony
Moderator: Jeff Roberts, Co-chair, Brainstorm Finance; Editor, The Ledger; Senior Writer, Law & Policy Reporter, FORTUNE
Photography by Rebecca Greenfield/Fortune
023
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
9:40 AM
HOW AI WILL CHANGE MEDICINE
The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.
Adrian Aoun, CEO and Founder, Forward
Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health
Julie Sweet, Chief Executive Officer, North America, Accenture
Moderator: Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
002
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:05 PM
SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT
The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.
The Fortune Brainstorm Health Co-Chairs:
Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health
Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health
Clifton Leaf, Fortune
Photograph by Stuart Isett/Fortune
004
Fortune Brainstorm HEALTH 2018
Monday, March 19th, 2018
Laguna Niguel, CA
2:45 PM
MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM
Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.
Deborah DiSanzo, General Manager, IBM Watson Health
Amy Powell, President, Paramount Television and Digital Entertainment
Bernard J. Tyson, Chairman and CEO, Kaiser Permanente
Moderator: Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
042
Fortune Brainstorm HEALTH 2018
Tuesday, March 20th, 2018
Laguna Niguel, CA
4:30 PM
A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN
Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors
Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media
Moderator:Arianna Huffington, Thrive Global
Photograph by Stuart Isett/Fortune
BANKING ON CHANGE
A decade after the financial crisis, Bank of America’s profits are at record highs, yet persistently low interest rates and rising recession fears pose risks. Meanwhile, online challengers and new technologies such as A.I. have pushed it to raise the bar on modern banking. A conversation with the head of one of America’s top banks about leading in uncertain times.
Brian Moynihan, Chairman and CEO, Bank of America
Moderator: Shawn Tully, Senior Editor-at-Large, FORTUNE
photo by Rebecca Greenfield for Fortune